JETRO × AZCA AI Pitch Event #2 - Life Science & Medical Devices

Cardiospire

Cardiospire has developed a ICU hemodynamic monitor that can extract pulmonary artery pressure and stroke volume non-invasively by tapping into the vent line through an access similar to a capnography port. Through use of AI, the same data streams can be extracted from regular breath providing the possibility of a powerful at-home monitoring tool for chronic lung diseases.

Osteoboost Health

Osteoboost is the first and only FDA-approved non-drug prescription treatment for low bone density with a TAM of $100B globally for the 100's of million patients with osteopenia (and osteoporosis). This wearable medical device uses patented precision vibration therapy to strengthen bones, slowing vertebral bone loss by over 80% in a gold-standard clinical trial.

VisCardia, Inc.

Despite significant advancements in pharmacologic therapies, many patients with heart failure continue to experience disabling symptoms, limited functional capacity, and poor quality of life, leaving a critical gap in treatment options. VisCardia's technology is a disruptive treatment concept which leverages the diaphragm’s ability to act as an ancillary cardiac pump and to address that gap.

Adaptyx Biosciences

Adaptyx Biosciences is developing a next-generation biosensor platform for continuous, minimally invasive monitoring of molecular biomarkers. Originating from Stanford University and based on over 15 years of research in Professor H. Tom Soh’s lab, the technology enables real-time tracking of small molecules and proteins over multiple days in a wearable format.

Scaled Cell Solutions

Existing cell therapy is costly and time consuming, primarily due to the complex manufacturing process of genetically modified cells. Scaled Cell Solutions is working to reduce the cost and time for treatment, while at the same time improving the safety and efficacy of cell therapy, by developing a vein-to-vein solution for cell therapy.

Attune Neurosciences

Attune Neurosciences helps improve human health and performance by creating clinically proven, non-invasive neurostimulation products. It is a medical device company. The company is initially targeting sleep- and wake-related conditions to support patients, the government, and industrial applications.

Vantis Vascular Inc

Vantis Vascular has developed a highly advanced integrated coronary delivery system that combines guide extension and microcatheter. Meticulously engineered, the system is designed to overcome numerous unmet clinical challenges in accessing target lesions in the most calcified, tortuous, vessels.

Developed and clinically evaluated an Extravascular, extracardiac, intrapericardial approach to treat CHF - Cardiogenic Shock patients.

Dopl Technologies Inc.

Dopl’s primary innovation is a telerobotic ultrasound system that allows a remote sonographer to perform diagnostic scans using a robotic arm controlled via the internet . Equipped with AI assistance and haptic feedback, the system lets clinicians “feel” tissue resistance as if they were in the same room. The AI layer optimizes scanning workflows, reducing exam times and improving image quality